Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advantan maintenance therapy after successful induction treatment for atopic dermatitis
2004-002673-22Phase 4Completed
- Sponsor
- Schering AG
- Start
- Jan 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in atopic dermatitis (AD) comparing Advantan maintenance with Advabas placebo control (2 arms). Primary endpoint: Time to relapse. Started Jan 2005; status: completed.
02
Drugs
methylprednisolone aceponate
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2004-002673-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002673-22.